Clinical Trial Update: Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening [Phase 4]

View source ↗

Summary

A completed Phase 4 clinical trial evaluating novel approaches to minimize drug-induced prolongation of the QT interval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Qt Syndrome

Snippet

Sponsor: Indiana University | Conditions: Long QT Syndrome, Abnormalities, Drug-Induced | Phase 4 | Status: COMPLETED